1. 5-Aminosalicylic acid in serum and urine after administration by enema to patients with colitis;Dew, M.J.; Cadwell, M.; Kidwai, N.S.; Evans, B.K.; Rhodes, E.J.;7 Pharm Pharmacology,1984
2. Nephrotoxic lesions from 5-aminosalicylic acid. BrMedJ';Calder, I.C.; Funder, C.C.; Green, C.R.; Ham, K.N.; Tange, J.D.,1972
3. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis;Dew, M.J.; Ryder, R.E.J.; Evans, N.; Evans, B.K.; Rhodes, E.J.;Brj Clin Pharmacol,1983
4. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder;Finkelstein, A.; Fraley, D.S.; Stachura, I.; Feldman, H.A.; Gandy, D.R.; Bourke, E.;AmJ7 Med,1982
5. Nephrotic syndrome induced by tolmetin;Chatterjee, G.P.;JAMA,1981